Search Results 131-140 of 20654 for colitis

1. C. difficile infection - Diagnosis and treatment - Mayo Clinic

   Colitis-induced TH17 cells increase the risk for severe subsequent Clostridium difficile infection. Cell Host and Microbe. 2019;25:756. Taur Y, et al ...

2. A Protocol Of Icotrokinra Therapy In Adult And Adolescent Participants With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   A Protocol Of Icotrokinra Therapy In Adult And Adolescent Participants With Moderately To Severely Active Ulcerative Colitis · Overview · Participation ...

3. Mayo Clinic Q and A: Treating inflammatory bowel disease

   It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...

4. Study of the Effect of SHP647 as Maintenance Treatment in Participants with Moderate to Severe Ulcerative Colitis who Achieved Clinical Response in Induction Studies - Mayo Clinic

   The purpose of this study is to evaluate the efficacy of SHP647 as maintenance therapy in participants with moderate to severe ulcerative colitis (UC) who ...

5. Ileoanal anastomosis (J-pouch) surgery - Mayo Clinic

   This surgery removes the large intestine. It's often done to treat ulcerative colitis and other bowel conditions.

6. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

   25–30 in San Antonio. Findings to be presented are: Patients with microscopic colitis do not have reduced risk of developing colon polyps. Cross-sectional ...

7. Infliximab (intravenous route) - Mayo Clinic

   Infliximab injection is used to reduce the symptoms of moderate-to-severely active Crohn's disease and ulcerative colitis in adults and children who have ...

8. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

9. Edward V. Loftus, Jr., M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Edward V. Loftus Jr., M.D., is a gastroenterologist studying ulcerative colitis and Crohn's disease.

10. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis · Overview.